These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1010873)

  • 1. The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers.
    Coe FL; Moran E; Kavalich AG
    J Chronic Dis; 1976 Dec; 29(12):793-800. PubMed ID: 1010873
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():171-7. PubMed ID: 6937993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers.
    Robertson WG; Peacock M; Nordin BE
    Clin Sci; 1971 May; 40(5):365-74. PubMed ID: 5556093
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of uric acid in calcium-oxalate nephrolithiasis].
    Hartung R
    Fortschr Med; 1977 Jan; 95(2):67. PubMed ID: 832834
    [No Abstract]   [Full Text] [Related]  

  • 5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary management of urinary risk factors in renal stone formers.
    Rao PN; Prendiville V; Buxton A; Moss DG; Blacklock NJ
    Br J Urol; 1982 Dec; 54(6):578-83. PubMed ID: 6295538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricosuric calcium oxalate nephrolithiasis.
    Coe FL
    Kidney Int; 1978 May; 13(5):418-26. PubMed ID: 661071
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic basis of renal-stone disease.
    Broadus AE; Thier SO
    N Engl J Med; 1979 Apr; 300(15):839-45. PubMed ID: 34098
    [No Abstract]   [Full Text] [Related]  

  • 10. Examination of the urinary potential of hyperuricosuric patients to retard calcium oxalate precipitation.
    Goldwasser B; Sarig S; Azoury R; Orda S; Boichis H; Wax Y; Many M
    Eur Urol; 1985; 11(1):40-3. PubMed ID: 3987747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of nutritional status, laboratory parameters and dietary patterns upon urinary acid excretion in calcium stone formers.
    Tessaro CZW; Ramos CI; Heilberg IP
    J Bras Nefrol; 2018; 40(1):35-43. PubMed ID: 29796583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution to therapeutic decisions of ratios, absolute values and other measures of calcium, magnesium, urate or oxalate balance in stone formers.
    Drach GW
    J Urol; 1976 Sep; 116(3):338-40. PubMed ID: 957503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E; Imperiali P; Badii M; Capiccioni S; Masi MG; Sasdelli M
    Proc Eur Dial Transplant Assoc; 1983; 20():445-9. PubMed ID: 6657667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The significance of uric acid in calcium oxalate nephrolithiasis].
    Hartung R
    MMW Munch Med Wochenschr; 1975 Mar; 117(10):387-90. PubMed ID: 804601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary urate and uric acid relative saturation in normouricuric calcium oxalate stone formers with normal urinary calcium oxalate saturation.
    Labeeuw M; Gerbaulet C; Pozet N; Zech P; Traeger J
    Adv Exp Med Biol; 1980; 122A():87-92. PubMed ID: 7424663
    [No Abstract]   [Full Text] [Related]  

  • 16. Change in inhibitory potential in urine of hyperuricosuric calcium oxalate stone formers effected by allopurinol and orthophosphates.
    Goldwasser B; Sarig S; Azoury R; Wax Y; Hirsch D; Perlberg S; Many M
    J Urol; 1984 Nov; 132(5):1008-11. PubMed ID: 6492268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
    Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The loss of circadian rhythmicity of urinary solute excretion in idiopathic stone formers.
    Sidhu H; Vaidyanathan S; Wangoo D; Thind SK; Nath R; Malakondaiah GC; Krishan K
    Br J Urol; 1989 Oct; 64(4):333-5. PubMed ID: 2819381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers.
    Trinchieri A; Mandressi A; Luongo P; Longo G; Pisani E
    Br J Urol; 1991 Mar; 67(3):230-6. PubMed ID: 2021806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and glucose load studies in uric acid, oxalic and hyperparathyroid stone formers.
    Schwille PO; Scholz D; Hagemann G; Sigel A
    Adv Exp Med Biol; 1974; 41():485-94. PubMed ID: 4832572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.